Predicting effect of anti-PD-1/PD-L1 inhibitors therapy for hepatocellular carcinoma by detecting plasma metabolite based on UHPLC-MS

• Botong Liu,
• Jinyu Shi,
• Rui Su,
• Ran Zheng,
• Fan Xing,
• Yuan Zhang,
• Nanya Wang,
• Huanwen Chen,
• Shouhua Feng

Affiliations

Botong Liu

State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, China

Jinyu Shi

The Cancer Center, The First Hospital of Jilin University, Changchun, China

Rui Su

State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, China

Ran Zheng

State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, China

Fan Xing

State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, China

Yuan Zhang

State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, China

Nanya Wang

The Cancer Center, The First Hospital of Jilin University, Changchun, China

Huanwen Chen

School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China

Shouhua Feng

State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, China